Hisopo

Related Terms

Azob, bitter aperitifs, borneol, bornylacetate, caffeic acid, camphene, chartreuse, decoction of qingre huoxue (QHR), diosmin, diterpenoid, European mint, ezob (Hebrew), flavonoids, geraniol, giant-hyssop herb, herb hyssop, hesperidin, holy herb, hyssop decoction, hyssop leaf extract, hyssop oil, hyssopin, hyssopos of Dioscorides, Hyssopus ambiguus (Trautv.) Iljin, Hyssopus cretaceus Dubjan., Hyssopus cuspidatus Boriss., Hyssopus ferganensis Boriss., Hyssopus latilabiatus C.Y.Wu & H.W.Li, Hyssopus lophanthoides Buch.-Ham.ex D.Don, Hyssopus macranthus Boriss., Hyssopus ocymifolius Lam., Hyssopus officinalis, Hyssopus officinalis L., Hyssopus seravschanicus (Dub.) Pazij, Hyssopus tianschanicus Boriss, isopinocamphone, Lamiaceae (family), limonene, linalool, marrubiin, oleanolic acid, Origanum aegypticum, Origanum syriacum, phellandrene, pinene, pinocamphone, polysaccharide MAR-10, QHR, resin, tannins, terpenoids, thujone, ursolic acid, volatile oil.

Background

The use of hyssop as an herbal remedy dates back to Biblical times. It is mentioned in both the Old and New Testaments of the Christian Bible as a cleansing agent (although these references may be to other species of hyssop, such as Origanum aegypticum or Origanum syriacum, rather than Hyssopus officinalis).
Hyssop has been prescribed for a multitude of medical conditions, although there are few high-quality human trials researching these uses. It has been used traditionally as an antispasmodic, expectorant, emmenagogue (stimulates menstruation), stimulant, carminative (digestive aid), peripheral vasodilator, anti-inflammatory, anticatarrhal, antispasmodic, tonic and sweat-inducer. However, both the alcoholic extract and decoction have been used to inhibit sweating. Hyssop is used specifically for cough, bronchitis and chronic catarrh, and also for its tonic effects on the digestive, urinary, nervous and bronchial systems. Hot hyssop decoction vapors have also been used to treat inflammation and tinnitus.

Evidence Table

These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. GRADE *
These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. GRADE *
* Key to grades

A: Strong scientific evidence for this use
B: Good scientific evidence for this use
C: Unclear scientific evidence for this use
D: Fair scientific evidence for this use (it may not work)
F: Strong scientific evidence against this use (it likley does not work)
* Key to grades

A: Strong scientific evidence for this use
B: Good scientific evidence for this use
C: Unclear scientific evidence for this use
D: Fair scientific evidence for this use (it may not work)
F: Strong scientific evidence against this use (it likley does not work)

Tradition / Theory

The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.

Dosing

Adults (over 18 years old)
There is no proven safe or effective dose for hyssop. In general, 2 grams of dried herb infused in boiling water three times daily has been given. Avoid sustained use of hyssop oil (10 to 30 drops daily for adults) due to a slight risk of seizures.

Safety

The U.S. Food and Drug Administration does not strictly regulate herbs and supplements. There is no guarantee of strength, purity or safety of products, and effects may vary. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy. Consult a healthcare provider immediately if you experience side effects.

Interactions

Interactions with Drugs
Hyssop may lower the seizure threshold and, theoretically, may interact with antiepileptic medications.
Daflon? 500 (a mixture of diosmin [90%] and hesperidin [10%]) may interact additively with anti-hyperglycemic (blood sugar altering) drugs. Caution is advised in patients with diabetes (high blood sugar) or hypoglycemia (low blood sugar), and in those taking drugs, herbs, or supplements that affect blood sugar. Serum glucose levels may need to be monitored by a qualified healthcare professional, including a pharmacist, and medication adjustments may be necessary.
Hyssop constituents oleanolic acid and ursolic acid have recognized anti-hyperlipidemic (cholesterol lowering) properties and may interact additively with anti-hyperlipidemia drugs.
Early studies showed that crude extracts of hyssop produced antiviral activity against herpes simplex and HIV-1. Therefore, hyssop may theoretically interact with antiviral medications.
A decoction of qingre huoxue, which includes hyssop, may interact additively with glucocorticoids.
Hyssop is proposed to possess immunomodulatory activity and may theoretically interact with immunosuppressant medications.
Hyssop is proposed to affect the seizure threshold and may therefore theoretically interact with medications that affect the seizure threshold.

Attribution

This information is based on a systematic review of scientific literature edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com).

Bibliography

Baek JH, Lee YS, Kang, CM, et al. Intracellular Ca2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int J Cancer 11-27-1997;73(5):725-728.
Burkhard PR, Burkhardt K, Haenggeli CA,et al. Plant-induced seizures: reappearance of an old problem. J Neurol 1999;246(8):667-670.
Cesarone MR, Belcaro G, Pellegrini L, et al. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study. Angiology 2005;56(1):1-8.
Deng YY, Chen YP, Wang L, et al. [Clinical study on treatment of mid-advanced crescentic nephritis by qingre huoxue recipe]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2004;24(12):1084-1086.
Es-saady D, Simon A, Ollier M, et al. Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest. Cancer Lett. 9-10-1996;106(2):193-197.
Gollapudi S, Sharma HA, Aggarwal S, et al. Isolation of a previously unidentified polysaccharide (MAR-10) from Hyssop officinalis that exhibits strong activity against human immunodeficiency virus type 1. Biochem.Biophys.Res.Commun. 5-5-1995;210(1):145-151.
Hoffmann D. Therapeutic herbalism. A correspondence course in phytotherapy. 1995;4:64-65.
Jantet G. RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids. Angiology 2000;51(1):31-37.
Jie L. Pharmacology of oleanolic acid and ursolic acid. Journal of Ethnopharmacology 1-2-1995;49(2-1):57-68.
Keenoy B, Vertommen J, De Leeuw I. The effect of flavonoid treatment on the glycation and antioxidant status in Type 1 diabetic patients. Diabetes Nutr Metab 1999;12(4):256-263.
Kreis W, Kaplan MH, Freeman J, et al. Inhibition of HIV replication by Hyssop officinalis extracts. Antiviral Res. 1990;14(6):323-337.
Millet Y, Jouglard J, Steinmetz MD, et al. Toxicity of some essential plant oils. Clinical and experimental study. Clin Toxicol. 1981;18(12):1485-1498.
Varga E, Hajdu Z, Veres K, et al. [Investigation of variation of the production of biological and chemical compounds of Hyssopus officinalis L.]. Acta Pharm Hung. 1998;68(3):183-188.